Summit Rock Advisors, LP Phathom Pharmaceuticals, Inc. Transaction History

Summit Rock Advisors, LP

  • $256 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021
SELL
$33.86 - $48.68 $8,465 - $12,170
-250 Reduced 0.73%
34,100 $1.28 Million
Q4 2020

Feb 12, 2021
SELL
$33.22 - $50.26 $14,151 - $21,410
-426 Reduced 1.22%
34,350 $1.14 Million
Q2 2020

Aug 10, 2020
BUY
$25.06 - $54.6 $871,486 - $1.9 Million
34,776 New
34,776 $1.14 Million

Others Institutions Holding PHAT

# of Institutions
143
Shares Held
74.8M
Call Options Held
42.3K
Put Options Held
45.7K
View Full List

About Phathom Pharmaceuticals, Inc.

PHAT Quotes by TradingView
  • Ticker PHAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,175,200
  • Market Cap $272M
  • Description
  • Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...
More about PHAT
Track This Portfolio

Track Summit Rock Advisors, LP Portfolio

Follow Summit Rock Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Rock Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Summit Rock Advisors, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email